Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
93.30
+1.07 (1.16%)
At close: Mar 3, 2026, 4:00 PM EST
92.70
-0.60 (-0.64%)
After-hours: Mar 3, 2026, 6:45 PM EST
Guardant Health Revenue
In the year 2025, Guardant Health had annual revenue of $982.02M with 32.88% growth. Guardant Health had revenue of $281.27M in the quarter ending December 31, 2025, with 39.37% growth.
Revenue (ttm)
$982.02M
Revenue Growth
+32.88%
P/S Ratio
12.46
Revenue / Employee
$391,868
Employees
2,506
Market Cap
12.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 982.02M | 243.01M | 32.88% |
| Dec 31, 2024 | 739.02M | 175.07M | 31.04% |
| Dec 31, 2023 | 563.95M | 114.41M | 25.45% |
| Dec 31, 2022 | 449.54M | 75.89M | 20.31% |
| Dec 31, 2021 | 373.65M | 86.92M | 30.32% |
| Dec 31, 2020 | 286.73M | 72.36M | 33.75% |
| Dec 31, 2019 | 214.38M | 123.74M | 136.52% |
| Dec 31, 2018 | 90.64M | 40.80M | 81.85% |
| Dec 31, 2017 | 49.84M | 24.59M | 97.40% |
| Dec 31, 2016 | 25.25M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.34B |
| Mettler-Toledo International | 4.03B |
| Charles River Laboratories International | 4.02B |
| Exact Sciences | 3.25B |
| Revvity | 2.86B |
GH News
- 20 hours ago - Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened - Business Wire
- 1 day ago - Carillon Eagle Small Cap Growth Fund Q4 2025 Portfolio Review - Seeking Alpha
- 4 days ago - Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 days ago - Allspring Smid Cap Growth Fund Q4 2025 Top Contributors And Detractors - Seeking Alpha
- 12 days ago - Allspring Mid Cap Growth Fund Q4 2025 Performance Insights, Portfolio Drivers & Decisions - Seeking Alpha
- 12 days ago - Guardant Health, Inc. (GH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook - Business Wire
- 19 days ago - Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open - PRNewsWire